EXELIXIS INC (1EXEL.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1EXEL - US30161Q1040 - Common Stock
30.7 EUR
-2.85 (-8.49%)
We assign a fundamental rating of 8 out of 10 to 1EXEL. 1EXEL was compared to 83 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making 1EXEL a very profitable company, without any liquidiy or solvency issues. An interesting combination arises when we look at growth and value: 1EXEL is growing strongly while it also seems undervalued. With these ratings, 1EXEL could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year 1EXEL was profitable.
- In the past year 1EXEL had a positive cash flow from operations.
- 1EXEL had positive earnings in each of the past 5 years.
- In the past 5 years 1EXEL always reported a positive cash flow from operatings.
1.2 Ratios
- 1EXEL has a better Return On Assets (22.49%) than 91.89% of its industry peers.
- With an excellent Return On Equity value of 29.62%, 1EXEL belongs to the best of the industry, outperforming 90.54% of the companies in the same industry.
- The Return On Invested Capital of 1EXEL (25.22%) is better than 97.30% of its industry peers.
- 1EXEL had an Average Return On Invested Capital over the past 3 years of 10.78%. This is in line with the industry average of 12.74%.
- The last Return On Invested Capital (25.22%) for 1EXEL is above the 3 year average (10.78%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.49% | ||
| ROE | 29.62% | ||
| ROIC | 25.22% |
ROA(3y)10.23%
ROA(5y)8.95%
ROE(3y)13.24%
ROE(5y)11.23%
ROIC(3y)10.78%
ROIC(5y)9.34%
1.3 Margins
- With an excellent Profit Margin value of 27.01%, 1EXEL belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
- 1EXEL's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 33.71%, 1EXEL belongs to the best of the industry, outperforming 90.54% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1EXEL has declined.
- 1EXEL has a Gross Margin of 96.59%. This is amongst the best in the industry. 1EXEL outperforms 94.59% of its industry peers.
- In the last couple of years the Gross Margin of 1EXEL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.71% | ||
| PM (TTM) | 27.01% | ||
| GM | 96.59% |
OM growth 3Y16.77%
OM growth 5Y-3.58%
PM growth 3Y14.28%
PM growth 5Y-6.24%
GM growth 3Y0.06%
GM growth 5Y-0.02%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1EXEL is creating value.
- The number of shares outstanding for 1EXEL has been reduced compared to 1 year ago.
- The number of shares outstanding for 1EXEL has been reduced compared to 5 years ago.
- There is no outstanding debt for 1EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- 1EXEL has an Altman-Z score of 10.91. This indicates that 1EXEL is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of 1EXEL (10.91) is better than 86.49% of its industry peers.
- There is no outstanding debt for 1EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 10.91 |
ROIC/WACC2.88
WACC8.75%
2.3 Liquidity
- A Current Ratio of 3.51 indicates that 1EXEL has no problem at all paying its short term obligations.
- With a decent Current ratio value of 3.51, 1EXEL is doing good in the industry, outperforming 68.92% of the companies in the same industry.
- 1EXEL has a Quick Ratio of 3.44. This indicates that 1EXEL is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 3.44, 1EXEL is doing good in the industry, outperforming 68.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.44 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 67.74% over the past year.
- The Earnings Per Share has been growing by 12.65% on average over the past years. This is quite good.
- Looking at the last year, 1EXEL shows a quite strong growth in Revenue. The Revenue has grown by 10.73% in the last year.
- The Revenue has been growing by 17.51% on average over the past years. This is quite good.
EPS 1Y (TTM)67.74%
EPS 3Y37.61%
EPS 5Y12.65%
EPS Q2Q%-15.58%
Revenue 1Y (TTM)10.73%
Revenue growth 3Y14.76%
Revenue growth 5Y17.51%
Sales Q2Q%-10.82%
3.2 Future
- The Earnings Per Share is expected to grow by 22.20% on average over the next years. This is a very strong growth
- Based on estimates for the next years, 1EXEL will show a quite strong growth in Revenue. The Revenue will grow by 10.31% on average per year.
EPS Next Y29.59%
EPS Next 2Y25.34%
EPS Next 3Y25.84%
EPS Next 5Y22.2%
Revenue Next Year7.2%
Revenue Next 2Y9.86%
Revenue Next 3Y11.44%
Revenue Next 5Y10.31%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- 1EXEL is valuated rather expensively with a Price/Earnings ratio of 17.06.
- Compared to the rest of the industry, the Price/Earnings ratio of 1EXEL indicates a rather cheap valuation: 1EXEL is cheaper than 85.14% of the companies listed in the same industry.
- 1EXEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.54.
- With a Price/Forward Earnings ratio of 12.20, 1EXEL is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EXEL indicates a rather cheap valuation: 1EXEL is cheaper than 93.24% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, 1EXEL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.06 | ||
| Fwd PE | 12.2 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1EXEL indicates a rather cheap valuation: 1EXEL is cheaper than 85.14% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, 1EXEL is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.66 | ||
| EV/EBITDA | 10.4 |
4.3 Compensation for Growth
- 1EXEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of 1EXEL may justify a higher PE ratio.
- A more expensive valuation may be justified as 1EXEL's earnings are expected to grow with 25.84% in the coming years.
PEG (NY)0.58
PEG (5Y)1.35
EPS Next 2Y25.34%
EPS Next 3Y25.84%
5. Dividend
5.1 Amount
- No dividends for 1EXEL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1EXEL (10/22/2025, 7:00:00 PM)
30.7
-2.85 (-8.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners96.89%
Inst Owner ChangeN/A
Ins Owners2.23%
Ins Owner ChangeN/A
Market Cap8.26B
Revenue(TTM)2.23B
Net Income(TTM)602.30M
Analysts76.92
Price Target38.31 (24.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.5%
Min EPS beat(2)13.99%
Max EPS beat(2)49.01%
EPS beat(4)4
Avg EPS beat(4)21.76%
Min EPS beat(4)10.66%
Max EPS beat(4)49.01%
EPS beat(8)6
Avg EPS beat(8)17.86%
EPS beat(12)9
Avg EPS beat(12)18.64%
EPS beat(16)12
Avg EPS beat(16)38.79%
Revenue beat(2)1
Avg Revenue beat(2)3.15%
Min Revenue beat(2)-3.02%
Max Revenue beat(2)9.31%
Revenue beat(4)2
Avg Revenue beat(4)3.21%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)9.31%
Revenue beat(8)3
Avg Revenue beat(8)4.17%
Revenue beat(12)5
Avg Revenue beat(12)2.6%
Revenue beat(16)7
Avg Revenue beat(16)2.9%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.7%
EPS NQ rev (3m)3.36%
EPS NY rev (1m)1.43%
EPS NY rev (3m)4.85%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.06 | ||
| Fwd PE | 12.2 | ||
| P/S | 4.28 | ||
| P/FCF | 12.66 | ||
| P/OCF | 12.37 | ||
| P/B | 4.7 | ||
| P/tB | 4.85 | ||
| EV/EBITDA | 10.4 |
EPS(TTM)1.8
EY5.86%
EPS(NY)2.52
Fwd EY8.19%
FCF(TTM)2.42
FCFY7.9%
OCF(TTM)2.48
OCFY8.09%
SpS7.17
BVpS6.54
TBVpS6.33
PEG (NY)0.58
PEG (5Y)1.35
Graham Number16.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.49% | ||
| ROE | 29.62% | ||
| ROCE | 32.1% | ||
| ROIC | 25.22% | ||
| ROICexc | 38.09% | ||
| ROICexgc | 39.72% | ||
| OM | 33.71% | ||
| PM (TTM) | 27.01% | ||
| GM | 96.59% | ||
| FCFM | 33.81% |
ROA(3y)10.23%
ROA(5y)8.95%
ROE(3y)13.24%
ROE(5y)11.23%
ROIC(3y)10.78%
ROIC(5y)9.34%
ROICexc(3y)19.16%
ROICexc(5y)19.43%
ROICexgc(3y)20.04%
ROICexgc(5y)20.66%
ROCE(3y)13.72%
ROCE(5y)11.89%
ROICexgc growth 3Y9.55%
ROICexgc growth 5Y2.44%
ROICexc growth 3Y10.88%
ROICexc growth 5Y3.03%
OM growth 3Y16.77%
OM growth 5Y-3.58%
PM growth 3Y14.28%
PM growth 5Y-6.24%
GM growth 3Y0.06%
GM growth 5Y-0.02%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 60.32% | ||
| Cap/Sales | 0.81% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.79% | ||
| Profit Quality | 125.2% | ||
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.44 | ||
| Altman-Z | 10.91 |
F-Score8
WACC8.75%
ROIC/WACC2.88
Cap/Depr(3y)129.54%
Cap/Depr(5y)238.73%
Cap/Sales(3y)1.75%
Cap/Sales(5y)2.56%
Profit Quality(3y)151.16%
Profit Quality(5y)151.8%
High Growth Momentum
Growth
EPS 1Y (TTM)67.74%
EPS 3Y37.61%
EPS 5Y12.65%
EPS Q2Q%-15.58%
EPS Next Y29.59%
EPS Next 2Y25.34%
EPS Next 3Y25.84%
EPS Next 5Y22.2%
Revenue 1Y (TTM)10.73%
Revenue growth 3Y14.76%
Revenue growth 5Y17.51%
Sales Q2Q%-10.82%
Revenue Next Year7.2%
Revenue Next 2Y9.86%
Revenue Next 3Y11.44%
Revenue Next 5Y10.31%
EBIT growth 1Y86.61%
EBIT growth 3Y34.01%
EBIT growth 5Y13.3%
EBIT Next Year41.83%
EBIT Next 3Y24.19%
EBIT Next 5YN/A
FCF growth 1Y108.65%
FCF growth 3Y25.89%
FCF growth 5Y5.48%
OCF growth 1Y98.36%
OCF growth 3Y20.43%
OCF growth 5Y5.84%
EXELIXIS INC / 1EXEL.MI FAQ
Can you provide the ChartMill fundamental rating for EXELIXIS INC?
ChartMill assigns a fundamental rating of 8 / 10 to 1EXEL.MI.
Can you provide the valuation status for EXELIXIS INC?
ChartMill assigns a valuation rating of 8 / 10 to EXELIXIS INC (1EXEL.MI). This can be considered as Undervalued.
What is the profitability of 1EXEL stock?
EXELIXIS INC (1EXEL.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of EXELIXIS INC (1EXEL.MI) stock?
The Price/Earnings (PE) ratio for EXELIXIS INC (1EXEL.MI) is 17.06 and the Price/Book (PB) ratio is 4.7.